20111 results for «»
20111 results
uRDN now - The third pillar for hypertension treatment
16 May 2024 – From EuroPCR 2024
Tune into this session to stay updated on the cutting-edge clinical evidence, guidelines, and technology surrounding renal denervation. Explore firsthand clinical experiences with ultrasound renal denervation and gain practical insights into patient selection through individual, real-world case discussions. Engage in discussions on integrating ultrasound renal denervation...
Robotic PCI: tips and tricks, challenging anatomies and future perspectives
14 May 2024 – From EuroPCR 2024
In this session, discover the effectiveness and safety of robotic PCI for both simple and complex lesions requiring additional devices like IVL, IVUS, laser, and FFR. Learn about the numerous benefits of robotics for patients and cathlab teams, including enhanced precision in wire navigation and stent...
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes
16 May 2024 – From EuroPCR 2024
Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...
Meet the EuroPCR 2024 Andreas Grüntzig Ethica Awardees
16 May 2024
Ottavio Alfieri and Frederick St Goar received the award for their important work on developing new opportunities for expanding indications of interventions targeting mitral regurgitation in patients with heart failure, with benefits including mortality reduction in selected cases. Find out more about the achievements of this...
Jasper Boeddinghaus
Basel, Switzerland
Relief for the unrelievable: the role of the Reducer for refractory angina
15 May 2024 – From EuroPCR 2024
Explore the incidence and impact of refractory angina, observe a real-life Reducer implantation procedure with step-by-step analysis and discussions, gain insight into the coronary sinus mechanism of action and implantation techniques, grasp the indications for the Reducer, and review available clinical data in this session.
Athanasios Papadis
Greece
Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions
16 May 2024 – From EuroPCR 2024
Explore this EuroPCR 2024 session for a comprehensive understanding of the imaging pathway in transcatheter tricuspid valve interventions, including diagnosis, therapy, and post-procedural follow-up, discover innovative, transformative imaging techniques such as 4D intracardiac echocardiography and dual-source photon-counting CT, and learn how these innovations can be applied in...
Left main and complex bifurcation stenting
14 May 2024 – From EuroPCR 2024
Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
Mechanical circulatory support in cardiogenic shock: where are we now?
14 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
From innovation to reality: the impact of Cre8 EVO technology on complex PCI
15 May 2024 – From EuroPCR 2024
This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...
ShortCut leads the way for leaflet modification
14 May 2024 – From EuroPCR 2024
Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...
Three tailored devices to ease the complex PCI procedures
14 May 2024 – From EuroPCR 2024
At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES?
14 May 2024 – From EuroPCR 2024
Follow this exchange between Antonio Colombo, Stefan Verheye, and Davide Capodanno as they discuss the past, present, and future of drug-eluting stents. They address the current limitations, emphasizing the issue of vessel caging, and suggest improvements, particularly highlighting the new Bioadaptor with uncaging bioresorbable elements that...
Mental health in the cathlab: is everything really ok?
14 May 2024 – From EuroPCR 2024
Watch Alison Dahlmann and Kristin Rykkje-Johannessen discuss the impact of working in a cathlab on mental health. Despite limited clinical evidence, a two-month online survey revealed that 93% of cathlab workers, across all healthcare professional categories, find the environment stressful, with over 92% experiencing stress and...
AID-ANGIO study: performing ad hoc microvascular assessment during diagnostic coronary angiography
14 May 2024 – From EuroPCR 2024
Christopher Cook interviews Javier Escaned to unravel the AID-ANGIO study, probing its purpose, methodology, and key outcomes. This study aimed to showcase the viability, safety, and diagnostic benefits of performing invasive functional testing ad hoc in managing patients with chronic coronary syndromes.
This interview was filmed at...
Innovations in cardiovascular interventions for chronic heart failure: where are we in 2024?
15 May 2024 – From EuroPCR 2024
Is there an ongoing need for interventions in chronic heart failure? At ACC, a significant trial unveiled interatrial shunting. What does this mean for patients? Explore the devices involved in neuromodulation and considerations for patient discussions. Who might benefit from intravascular monitoring? Watch Giuseppe Rosano and...
